Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 863394-07-4 Chemical Structure| 863394-07-4

Structure of Se-Methylselenocysteine HCl
CAS No.: 863394-07-4

Chemical Structure| 863394-07-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Se-Methylselenocysteine hydrochloride is a precursor of methylselenium with significant anticancer chemopreventive and antioxidant activity. This compound can induce apoptosis and has oral bioactivity, widely used in cancer prevention and antioxidant research.

Synonyms: Methylselenocysteine hydrochloride; Se-Methylseleno-L-cysteine hydrochloride; Se-methyl-L-Selenocysteine

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Se-Methylselenocysteine HCl

CAS No. :863394-07-4
Formula : C4H10ClNO2Se
M.W : 218.54
SMILES Code : O=C(O)[C@@H](N)C[Se]C.[H]Cl
Synonyms :
Methylselenocysteine hydrochloride; Se-Methylseleno-L-cysteine hydrochloride; Se-methyl-L-Selenocysteine
English Name :(R)-2-Amino-3-(methylselanyl)propanoic acid hydrochloride
MDL No. :MFCD03412450
InChI Key :JMPVTFHGWJDSDV-DFWYDOINSA-N
Pubchem ID :11957622

Safety of Se-Methylselenocysteine HCl

Related Pathways of Se-Methylselenocysteine HCl

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
293T embryonic kidney cells 50-200 µM 24-48 hours No cytotoxicity was observed Cell Prolif. 2021 May;54(5):e13038
L6 myoblast cells 50-200 µM 24-48 hours No cytotoxicity was observed Cell Prolif. 2021 May;54(5):e13038
Hepa1-6 hepatoma cells 50-200 µM 24-48 hours Not sensitive to SeMC treatment Cell Prolif. 2021 May;54(5):e13038
CT26 colon carcinoma cells 50-200 µM 24-48 hours Not sensitive to SeMC treatment Cell Prolif. 2021 May;54(5):e13038
4T1 mammary carcinoma cells 50-200 µM 24-48 hours Not sensitive to SeMC treatment Cell Prolif. 2021 May;54(5):e13038
TM6 mouse mammary epithelial tumor cells 100 µM 16 and 24 hours To study the effect of MSC on PI3-K activity, results showed that MSC reduced PI3-K activity by 73% and 84% at 16 and 24 hours, respectively. Breast Cancer Res. 2005;7(5):R699-707
TM6 mouse mammary epithelial tumor cells 50 µM 16 hours To study the effect of MSC on DNA synthesis, results showed that MSC inhibited 33% of DNA synthesis at 16 hours. Breast Cancer Res. 2005;7(5):R699-707
Human neuroblastoma SH-SY5Y cells 1 µM 24 hours To investigate the effect of MSC on apoptosis in Clu-knockdown SH-SY5Y cells. Results showed that 1 μM MSC could reverse the decrease in antioxidative capacity, Bcl-2/Bax ratio, and increase in caspase-8 activity caused by Clu-knockdown, thereby inhibiting apoptosis and maintaining cell viability. Int J Mol Sci. 2014 Nov 18;15(11):21331-47
Mouse neuroblastoma N2a cells 1 µM 24 hours To investigate the effect of MSC on apoptosis in Clu-knockdown N2a cells. Results showed that 1 μM MSC could reverse the decrease in antioxidative capacity, Bcl-2/Bax ratio, and increase in caspase-8 activity caused by Clu-knockdown, thereby inhibiting apoptosis and maintaining cell viability. Int J Mol Sci. 2014 Nov 18;15(11):21331-47
A549 lung adenocarcinoma cells 50-200 µM 24-48 hours SeMC inhibited A549 cell growth in a dose-dependent manner Cell Prolif. 2021 May;54(5):e13038
Primary human hepatocytes 1218 ± 364 µM (IC50) 72 hours Evaluate the cytotoxicity of MSC on primary human hepatocytes, the IC50 value was 1218 ± 364 µM Antioxidants (Basel). 2021 Jul 7;10(7):1094
Huh7 cells 1294 ± 336 µM (IC50) 72 hours Evaluate the cytotoxicity of MSC on HCC cell lines, the IC50 value of Huh7 cells was 1294 ± 336 µM Antioxidants (Basel). 2021 Jul 7;10(7):1094
Hep3B cells 1875 ± 171 µM (IC50) 72 hours Evaluate the cytotoxicity of MSC on HCC cell lines, the IC50 value of Hep3B cells was 1875 ± 171 µM Antioxidants (Basel). 2021 Jul 7;10(7):1094
HEPG2 cells 1152 ± 188 µM (IC50) 72 hours Evaluate the cytotoxicity of MSC on HCC cell lines, the IC50 value of HEPG2 cells was 1152 ± 188 µM Antioxidants (Basel). 2021 Jul 7;10(7):1094

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice FaDu and A253 head and neck squamous cell carcinoma xenograft models Oral 0.2 mg/mouse/day Daily administration for 7 days (before chemotherapy) and 7 days (after chemotherapy) Se-methylselenocysteine significantly protected against organ-specific toxicity induced by lethal doses of cyclophosphamide, cisplatin, oxaliplatin, and irinotecan, including diarrhoea, stomatitis, alopecia, bladder, kidney, and bone marrow toxicities. Protection from lethal toxicity by MSC was associated with enhanced antitumour activity in rats bearing advanced Ward colorectal carcinoma and in nude mice bearing human squamous cell carcinoma of the head and neck, FaDu, and A253xenografts. Antioxidants (Basel). 2019 Jul 5;8(7):207
Fischer 344/N rats Ward colorectal carcinoma model Oral 0.25 to 1.25 mg/rat/day Daily administration for 14 days (before chemotherapy) and 7 days (after chemotherapy) Se-methylselenocysteine significantly protected against organ-specific toxicity induced by lethal doses of cyclophosphamide, cisplatin, oxaliplatin, and irinotecan, including diarrhoea, stomatitis, alopecia, bladder, kidney, and bone marrow toxicities. Protection from lethal toxicity by MSC was associated with enhanced antitumour activity in rats bearing advanced Ward colorectal carcinoma and in nude mice bearing human squamous cell carcinoma of the head and neck, FaDu, and A253xenografts. Antioxidants (Basel). 2019 Jul 5;8(7):207
BALB/c nude mice A549 lung carcinoma xenograft model Intratumoral injection 2 mg/kg SeMC and 2 mg/kg EBN Every four days from day 3 to day 27 SeMC/EBN@Gel significantly inhibited tumor growth Cell Prolif. 2021 May;54(5):e13038

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.58mL

0.92mL

0.46mL

22.88mL

4.58mL

2.29mL

45.76mL

9.15mL

4.58mL

 

Historical Records

Categories